Business News In Brief
Sheffield Today - GlaxoSmithKline rose 0.2 percent after it said on Friday it won approval to sell a new once-a-day formulation of its Coreg hypertension drug. AstraZeneca rose 0.4 percent after the FDA on Friday approved its Seroquel bipolar depression treatment.
Source: www.sheffieldtoday.net
UPDATE 4-Biovail stock up on dividend hike, strategy shift
Reuters - BVF.N: Quote , Profile , Research ) said on Wednesday it plans to triple its dividend, pay off debt and focus on drug development as it readies for copycat drugs that will challenge its main anti-depression treatment. The company will also axe its U.S
Source: today.reuters.com
Older Men Seek And Receive Depression Care Less Frequently Due To
Medical News Today - The UC Davis researchers analyzed gender differences in history of depression treatment, as well as referral rates and symptoms. To better understand lower rates of depression treatment and referral to IMPACT of older men, the researchers also
Source: www.medicalnewstoday.com
GET A QUOTE:
USA Today - Late in the day, the panel's chairwoman, Kyra Becker of the University of Washington School of Medicine, told Cyberonics that "it's unclear" whether the depression treatment should be approved. At 4:10 p.m., the panel took a break. A few minutes later
Source: www.usatoday.com
Depression Related News
KXAN - The physical examination will either diagnosis and/or rule out any medical conditions (such as thyroid disease, cancers or neurologic diseases) that could be causing the depression. Treatment Treatment usually involves medication, psychotherapy or a
Source: www.kxan.com
Click here for more information about seasonal depression seasonal depression
<< Home